Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Natera's Q1 Revenues Jump 31 Percent

Natera's Q1 Revenues Jump 31 Percent

May 10, 2016
|
staff reporter

NEW YORK (GenomeWeb) – Natera's first quarter 2016 revenues increased 31 percent over the first quarter of 2015, the company said after the close of the market on Tuesday.

Natera generated total revenues of $61.9 million in the first quarter 2016, up from $47.4 million in the first quarter of 2015. It beat analysts' average estimate of $48.2 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Featured Webinar

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
27
Featured Webinar

The Promise of Liquid Biopsy for Cancer Diagnostics and Therapeutic Monitoring: Are We There Yet?

Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.

What's Popular?

In Sequencing

  1. Illumina's Stock Falls 9 Percent on Grail Acquisition Rumors

  2. Scipher Medicine Taps Ambry Genetics to Scale Up TNF Inhibitor Response Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.